Free Access
Vet. Res.
Volume 38, Number 1, January-February 2007
Page(s) 1 - 14
Published online 01 November 2006
How to cite this article Vet. Res. (2007) 1-14
References of  Vet. Res. 38 (2007) 1-14
  1. Barrett T., Inglis S.C., Growth, purification and titration of influenza virus, in: Mahy B.W.J., Virology, a practical approach, IRL Press Oxford, Washington, 1985, pp. 119-150.
  2. Bassaganya R.J., Hontecillas R., Zimmerman D.R., Wannemuehler M.J., Long-term influence of lipid nutrition on the induction of CD8+ responses to viral or bacterial antigens, Vaccine (2002) 20:1435-1444 [CrossRef] [PubMed].
  3. Bikour M.H., Cornaglia E., Elazhary Y., Comparative study of the immunnostimulatory properties of different adjuvants administered with in inactivated influenza virus vaccine and evaluation of passive immunity in pigs, Immunol. Infect. Dis. (1994) 4:166-172.
  4. Bikour M.H., Cornaglia E., Weber J.M., Elazhary Y., Antigenic characterization of an H3N2 swine influenza virus isolated from pigs with proliferative and necrotizing pneumonia in Quebec, Can. J. Vet. Res. (1994) 58:287-290 [PubMed].
  5. Bikour M.H., Cornaglia E., Elazhary Y., Evaluation of a protective immunity induced by an inactivated influenza H3N2 vaccine after an intratracheal challenge of pigs, Can. J. Vet. Res. (1996) 60:312-314 [PubMed].
  6. Brown I.H., The epidemiology and evolution of influenza viruses in pigs, Vet. Microbiol. (2000) 74:29-46 [CrossRef] [PubMed].
  7. Charley B., Petit E., Leclerc C., Stefanos S., Production of porcine interleukine-2 and its biological and antigenic relationships with human interleukine-2, Immunol. Lett. (1985) 10:121-126 [CrossRef] [PubMed].
  8. Charley B., Fradelizi D., Differential effects of human and porcine interleukine 2 on natural killing (NK) activity of newborn piglets and adult pigs lymphocytes, Ann. Rech. Vet. (1987) 18:227-232 [PubMed].
  9. De Bruin T.G.M., Van Rooij E.M.A., De Visser Y.E., Bianchi A.T.J., Cytolytic function for Pseudorabis Virus-Stimulated Porcine CD4+ CD8 $^{\rm dull+ }$Lymphocytes, Viral Immunol. (2000) 13:511-520 [PubMed].
  10. Easterday B.A., Hinshaw V.S., Swine influenza, in: Leman A.D. et al. (Eds.), Disease in swine, Iowa State press, Ames, 1992, pp. 349-357.
  11. ElAzhary Y., Makabi-Panzu B., Hurley D.J., Laurent S., Delivery system for entrapping charged macromolecules and a method for preparing same, US patent No. 6,5552,004, 2003.
  12. Epstein S.L., Chia-Yun L., Misplon J.A., Bennink J.R., Mechanism of protective immunity against influenza virus infection in mice without antibodies, J. Immunol. (1998) 160:322-327 [PubMed].
  13. Foss D.L., Murtaugh M.P., Role of macrophage cytokines in mucosal adjuvanticity, Adv. Vet. Med. (1999) 41:83-104 [PubMed].
  14. Gourreau J.M., Hannoun C., Kaiser C., Jestin A., Excretion of human influenza virus by experimentally infected pigs, Comp. Immunol. Microbiol. Infect. Dis. (1980) 3:137-146 [PubMed].
  15. Haesebrouck F., Biront P., Pensaert M.B., Leunen J., Epizootics of respiratory tract disease in swine in Belgium due to H3N2 influenza virus and experimental reproduction of disease, Am. J. Vet. Res. (1985) 46:1926-1928 [PubMed].
  16. Haesebrouck F., Pensaert M.B., Effect of intratracheal challenge of fattening pigs previously immunized with an inactivated influenza H1N1 vaccine, Vet. Microbiol. (1986) 11:239-249 [CrossRef] [PubMed].
  17. Heinen P.P., van Nieuwstadt A.P., de Boer-Luijtze E.A., Bianchi A.T., Analysis of the quality of protection induced by a porcine influenza A vaccine to challenge with an H3N2 virus, Vet. Immunol. Immunopathol. (2001) 82:39-56 [PubMed].
  18. Heinen P.P., Rijsewijk F.A., de Boer-Luijtze E.A., Bianchi A.T., Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus, J. Gen. Virol. (2002) 83:1851-1859 [PubMed].
  19. Janeway C.A., Travers P., Walport M., Capra J.D., Host defense against infection, in: Immunobiology: The Immune System in Health and Disease, Elsevier/Garland, Amsterdam/London, 1999, pp. 363-415.
  20. Knoblock K.F., Canning P.C., Modulation of in vitro porcine natural killer cell activity by recombinant interleukine-1 alpha, interleukine-2 and interleukine-4, Immunology (1992) 76:229-304 [PubMed].
  21. Larsen D.L., Karasin A., Zuckermann F., Olsen C.W., Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting, Vaccine (2001) 19:2842-2853 [CrossRef] [PubMed].
  22. Meier W.A., Galeota J., Osorio F.A., Husmann R.J., Schnitzlein W.M., Zuckermann F.A., Gradual development of the interferon-gamma response of swine to porcine reproductive and respiratory syndrome virus infection or vaccination, Virology (2003) 25:18-31 [CrossRef].
  23. Meulemans G., Inter-species transmission of the influenza virus, Bull. Mem. Acad. R. Med. Belg. (1999) 154:263-267 [PubMed].
  24. Moskophidis D., Kioussis D., Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model, J. Exp. Med. (1998) 188:223-232 [CrossRef] [PubMed].
  25. Olsen C.W., Carey S., Hinshaw L., Karasin A.I., Virologic and serologic surveillance for human, swine and avian influenza virus infection among pigs in the north-central United States, Arch. Virol. (2000) 145:1399-1419 [CrossRef] [PubMed].
  26. Pastoret P.P., Veterinary vaccinology, C.R. Acad. Sci. Paris, Sciences de la vie - Life Sciences, 32, 1999, pp. 927-967.
  27. Pescovitz M.D., Sakopoulos A.G., Gaddy J.A., Husman R.J., Zuckermann F.A., Porcine peripheral blood CD4+CD8+ dual expressing T-cells, Vet. Immunol. Immunopathol. (1994) 43:53-62 [PubMed].
  28. Rodriguez-Carreno M.P., Lopez-Fuertes L., Revilla C., Ezquerra A., Alonso F., Dominguez J., Phenotypic characterization of porcine IFN-gamma-producing lymphocytes by flow cytometry, J. Immunol. Methods (2002) 259:171-179 [CrossRef] [PubMed].
  29. Saalmuller A., Pauly T., Hohlich B.J., Pfaff E., Characterization of porcine T lymphocytes and their immune response against viral antigens, J. Biotechnol. (1999) 20:223-233 [CrossRef].
  30. Salmon H., Charley B., Labonnardiere C., Olivier M., Kelley K., Paraf A., Natural killer (NK) activity and interferon (IFN) production by a fraction of spleen and blood lymphocytes in swine, Vet. Immunol. Immunopathol. (1989) 23:113-128 [PubMed].
  31. Summerfield A., Rziha H.J., Saalmuller A., Functional characterization of porcine CD4+CD8+ extrathymic T-lymphocytes, Cell. Immunol. (1996) 168:291-296 [CrossRef] [PubMed].
  32. Suzuki T., Horiike G., Yamazaki Y., Swine influenza virus strains recognize sialylsugar chains containing the molecular species of sialic acid predominantly present in the swine tracheal epithelium, FEBS Lett. (1997) 404:192-196 [CrossRef] [PubMed].
  33. Thompson W.R., Use of moving averages and interpolation to estimate median-effective dose: I. Fundamental formulas, estimation of error, and relation to other methods, Bacteriol. Rev. (1947) 11:115-145 [PubMed].
  34. Van Reeth K., Labarque G., De Clercq S., Pensaert M., Efficacy of vaccination of pigs with different H1N1 swine influenza viruses using a recent challenge strain and different parameters of protection, Vaccine (2001) 4:4479-4486 [CrossRef].
  35. Van Reeth K., Van Gucht S., Pensaert M., Correlations between lung proinflammatory cytokine levels, virus replication, and disease after swine influenza virus challenge of vaccination-immune pigs, Viral Immunol. (2002) 15:583-594 [PubMed].
  36. Waters W.R., Hontecillas R., Sacco R.E., Zuckermann F.A., Harkins K.R., Bassaganyariera J., Wannemuehler M.J., Antigen-specific proliferation of porcine CD8 $\alpha \alpha $ cells to an extracellular bacterial pathogen, Immunology (2000) 101:333-341 [PubMed].
  37. Wuethrich B., Chasing the Fickle Swine flu, Science (2003) 299:1502-1505 [CrossRef].
  38. Zuckermann F.A., Husmann R.J., Functional and phenotypic analysis of porcine peripheral blood CD4/CD8, Immunology (1996) 87:500-512 [PubMed].
  39. Zuckermann F.A., Extrathymic CD4/CD8 double positive T cells, Vet. Immunol. Immunopathol. (1999) 15:55-66.